{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:43:17Z","timestamp":1793328197536,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.arcmed.2021.07.003","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T17:12:37Z","timestamp":1627751557000},"page":"788-797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Roles of Coagulation Abnormalities and Microthrombosis in Sepsis: Pathophysiology, Diagnosis, and Treatment"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-4088","authenticated-orcid":false,"given":"Toshiaki","family":"Iba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9021-8633","authenticated-orcid":false,"given":"Hideo","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3766-4962","authenticated-orcid":false,"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2021.07.003_bib0001","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.arcmed.2021.07.003_bib0002","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/00003246-200009001-00004","volume":"28","author":"Taylor","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0003","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00001721-200501000-00011","article-title":"Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation","volume":"16","author":"Toh","year":"2005","journal-title":"Blood Coagl Fibrinolysis"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0004","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.thromres.2008.07.006","article-title":"Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsis","volume":"123","author":"Gando","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017046","article-title":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey","volume":"7","author":"Iba","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0006","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2052-0492-2-20","article-title":"Classifying types of disseminated intravascular coagulation: clinical and animal models","volume":"2","author":"Asakura","year":"2014","journal-title":"J Intensive Care"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0007","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1111\/jth.14946","article-title":"Underlying disorders of disseminated intravascular coagulation: Communication from the ISTH SSC Subcommittees on Disseminated Intravascular Coagulation and Perioperative and Critical Care Thrombosis and Hemostasis","volume":"18","author":"Squizzato","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0008","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/jth.12596","article-title":"Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan","volume":"12","author":"Iba","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0009","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jvs.2018.04.029","article-title":"Imbalance of coagulation and fibrinolysis can predict vascular access failure in patients on hemodialysis after vascular access intervention","volume":"69","author":"Hasuike","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.thromres.2019.04.030","article-title":"Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis. The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseases","volume":"179","author":"Iba","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0011","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12959-017-0142-4","article-title":"The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis","volume":"15","author":"Wada","year":"2017","journal-title":"Thromb J"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0012","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/bjh.17172","article-title":"Disseminated intravascular coagulation: epidemiology, biomarkers, and management","volume":"192","author":"Adelborg","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0013","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/jth.14566","article-title":"Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy?","volume":"17","author":"Levy","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0014","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/CCM.0000000000004458","article-title":"Coagulopathy of Coronavirus Disease 2019","volume":"48","author":"Iba","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0015","article-title":"Therapeutic strategies in patients with coagulopathy and disseminated intravascular coagulation: awareness of the phase-dependent characteristics","author":"Iba","year":"2021","journal-title":"Minerva Med"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0016","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1538-7836.2007.02865.x","article-title":"Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis","volume":"6","author":"Ma","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0017","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0018","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.thromres.2019.04.025","article-title":"Role of disseminated intravascular coagulation in severe sepsis","volume":"178","author":"Gando","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0019","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-2001-18866","article-title":"The tissue factor pathway in disseminated intravascular coagulation","volume":"27","author":"\u00d8sterud","year":"2001","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"10.1016\/j.arcmed.2021.07.003_bib0020","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/00003246-200107001-00015","article-title":"Endothelial cell dysfunction and coagulation","volume":"29","author":"Vallet","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185431","article-title":"Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4","volume":"12","author":"Matus","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0022","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40560-018-0340-6","article-title":"Role of extracellular vesicles in the development of sepsis-induced coagulopathy","volume":"6","author":"Iba","year":"2018","journal-title":"J Intensive Care"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0023","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/jth.13911","article-title":"Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis","volume":"16","author":"Iba","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0024","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.blre.2015.12.004","article-title":"DAMP and DIC: The role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC","volume":"30","author":"Ito T","year":"2016","journal-title":"Blood Rev"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0026","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1160\/TH15-08-0687","article-title":"Antithrombin: antiinflammatory properties and clinical applications","volume":"115","author":"Levy","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0027","first-page":"J7","article-title":"Endothelial dysfunction and inhibition of converting enzyme","volume":"19","author":"Vanhoutte","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0028","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fmed.2020.00543","article-title":"Impact of Von Willebrand Factor on Bacterial Pathogenesis","volume":"7","author":"Steinert","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0029","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/jth.14371","article-title":"Derangement of the endothelial glycocalyx in sepsis","volume":"17","author":"Iba","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0030","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.thromres.2012.01.015","article-title":"A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis","volume":"130","author":"Hayakawa","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0031","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.CCM.0000104941.89570.5F","article-title":"Pro- and antifibrinolytic properties of human pulmonary microvascular versus artery endothelial cells: impact of endotoxin and tumor necrosis factor-alpha","volume":"32","author":"Muth","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0032","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0033-1334140","article-title":"Role of fibrinolysis in sepsis","volume":"39","author":"Gando","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0033","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1055\/s-0035-1556730","article-title":"Coagulopathy of Acute Sepsis","volume":"41","author":"Semeraro","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0034","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000202209.42491.38","article-title":"A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria","volume":"34","author":"Gando","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0035","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1055\/s-0034-1395155","article-title":"A short contemporary history of disseminated intravascular coagulation","volume":"40","author":"Levi","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0036","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ams2.411","article-title":"Diagnosis of sepsis-induced disseminated intravascular coagulation and coagulopathy","volume":"6","author":"Iba","year":"2019","journal-title":"Acute Med Surg"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0037","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/jth.14578","volume":"17","author":"Iba","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0038","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1177\/1076029618770273","article-title":"Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin","volume":"24","author":"Iba","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0039","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jth.13230","article-title":"Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials","volume":"14","author":"Umemura","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0040","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/jth.14354","article-title":"Differential diagnoses for sepsis-induced disseminated intravascular coagulation: communication from the SSC of the ISTH","volume":"17","author":"Iba","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0041","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40560-019-0387-z","article-title":"Sepsis-associated disseminated intravascular coagulation and its differential diagnoses","volume":"7","author":"Iba","year":"2019","journal-title":"J Intensive Care"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0042","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12959-018-0168-2","article-title":"Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy","volume":"16","author":"Wada","year":"2018","journal-title":"Thromb J"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0043","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13054-018-2073-2","article-title":"Thrombocytopenia in the ICU: disseminated intravascular coagulation and thrombotic microangiopathies-what intensivists need to know","volume":"22","author":"Vincent","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0044","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1160\/TH16-06-0435","article-title":"Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia","volume":"116","author":"Warkentin","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/ams2.659","article-title":"The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020","author":"Egi","year":"2021","journal-title":"Acute Med Surg"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0046","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/CCM.0000000000004426","article-title":"Effect of a recombinant human soluble thrombomodulin on baseline coagulation biomarker levels and mortality outcome in patients with sepsis-associated coagulopathy","volume":"48","author":"Levi","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0047","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.thromres.2018.12.003","article-title":"Low D-dimer levels in sepsis: Good or bad?","volume":"174","author":"Semeraro","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0048","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.thromres.2005.06.007","article-title":"TAFI and PAI-1 levels in human sepsis","volume":"118","author":"Zeerleder","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0049","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40560-017-0238-8","article-title":"Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis","volume":"5","author":"Hoshino","year":"2017","journal-title":"J Intensive Care"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.blre.2015.10.002","article-title":"Potential diagnostic markers for disseminated intravascular coagulation of sepsis","volume":"30","author":"Iba","year":"2016","journal-title":"Blood Rev"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0051","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1055\/s-0037-1616753","volume":"86","author":"Wada","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0052","article-title":"Plasma Endothelial Glycocalyx Components as a Potential Biomarker for Predicting the Development of Disseminated Intravascular Coagulation in Patients With Sepsis","author":"Huang","year":"2020","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0053","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1160\/TH15-08-0687","article-title":"Antithrombin: antiinflammatory properties and clinical applications","volume":"115","author":"Levy","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0054","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2174\/157016112801784549","article-title":"Crosstalk between inflammation and coagulation: the lessons of sepsis","volume":"10","author":"van der Poll","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0055","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1055\/s-0029-1145256","article-title":"Sepsis, coagulation, and antithrombin: old lessons and new insights","volume":"34","author":"Levi","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0056","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/jth.12643","article-title":"Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study","volume":"12","author":"Tagami","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0057","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1378\/chest.104.3.882","article-title":"Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation","volume":"104","author":"Fourrier","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0058","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00024382-199711000-00003","article-title":"Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction","volume":"8","author":"Inthorn","year":"1997","journal-title":"Shock"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0059","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s001340050576","article-title":"Antithrombin III (ATIII) replacement therapy in patients with sepsis and\/or postsurgical complications: a controlled double-blind, randomized, multicenter study","volume":"24","author":"Baudo","year":"1998","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1538-7836.2005.01697.x","article-title":"Treatment effects of high dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation","volume":"4","author":"Kienast","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0061","doi-asserted-by":"crossref","first-page":"R297","DOI":"10.1186\/cc13163","article-title":"A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis","volume":"17","author":"Gando","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0062","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40560-018-0339-z","article-title":"An open-label, randomized, phase 3 study of the efficacy and safety of antithrombin gamma in patients with sepsis-induced disseminated intravascular coagulation syndrome","volume":"6","author":"Endo","year":"2018","journal-title":"J Intensive Care"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0063","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13054-019-2552-0","article-title":"Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential","volume":"23","author":"Ito","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0064","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0065","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","article-title":"A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation","volume":"41","author":"Vincent","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0066","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012850","article-title":"Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial","volume":"6","author":"Hagiwara","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0067","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13613-021-00842-4","article-title":"Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET","volume":"11","author":"Fran\u00e7ois","year":"2021","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0068","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3892\/etm.2013.1466","article-title":"Low-dose heparin as treatment for early disseminated intravascular coagulation during sepsis: A prospective clinical study","volume":"7","author":"Liu","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0069","first-page":"20074","article-title":"Impacts of early anticoagulant therapy on tissue perfusion in patients with sepsis","volume":"9","author":"Yang","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.arcmed.2021.07.003_bib0070","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440921001624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440921001624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:51:19Z","timestamp":1759261879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440921001624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0188440921001624"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2021.07.003","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles of Coagulation Abnormalities and Microthrombosis in Sepsis: Pathophysiology, Diagnosis, and Treatment","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2021.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}